Log in

LON:INHCInduction Healthcare Group Share Price, Forecast & News

GBX 110
+4.50 (+4.27 %)
(As of 07/10/2020 04:00 PM ET)
Today's Range
Now: GBX 110
50-Day Range
MA: GBX 98.89
52-Week Range
Now: GBX 110
Volume48,119 shs
Average VolumeN/A
Market Capitalization£46.26 million
P/E RatioN/A
Dividend YieldN/A
Induction Healthcare Group PLC operates as a healthcare technology company in the United Kingdom and Australia. It offers Induction Switch, a mobile application module that provides directory, document sharing, secure messaging services to enable healthcare professionals communicate with each other. The company was incorporated in 2019 and is based in London, the United Kingdom.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.82 out of 5 stars

Industry, Sector and Symbol

Industry Health Information Services
Phone44 33 3939 8091



Sales & Book Value

Annual SalesN/A
Cash FlowGBX 51.15 per share
Book ValueGBX 47.90 per share



Market Cap£46.26 million
Next Earnings DateN/A
OptionableNot Optionable

Receive INHC News and Ratings via Email

Sign-up to receive the latest news and ratings for INHC and its competitors with MarketBeat's FREE daily newsletter.

Induction Healthcare Group (LON:INHC) Frequently Asked Questions

How has Induction Healthcare Group's stock been impacted by COVID-19 (Coronavirus)?

Induction Healthcare Group's stock was trading at GBX 91 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, INHC stock has increased by 20.9% and is now trading at GBX 110. View which stocks have been most impacted by Coronavirus.

Has Induction Healthcare Group been receiving favorable news coverage?

News headlines about INHC stock have trended somewhat positive this week, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Induction Healthcare Group earned a news sentiment score of 1.3 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View the latest news about Induction Healthcare Group.

Who are some of Induction Healthcare Group's key competitors?

Who are Induction Healthcare Group's key executives?

Induction Healthcare Group's management team includes the following people:
  • Mr. Ibraheem Mahmood, CEO & Director
  • Mr. Sebastien Jantet, CFO & Director
  • Mr. Dale Scott Jessop, Chief Technology Officer

What is Induction Healthcare Group's stock symbol?

Induction Healthcare Group trades on the London Stock Exchange (LON) under the ticker symbol "INHC."

How do I buy shares of Induction Healthcare Group?

Shares of INHC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Induction Healthcare Group's stock price today?

One share of INHC stock can currently be purchased for approximately GBX 110.

How big of a company is Induction Healthcare Group?

Induction Healthcare Group has a market capitalization of £46.26 million.

What is Induction Healthcare Group's official website?

The official website for Induction Healthcare Group is www.inductionhealthcare.com.

How can I contact Induction Healthcare Group?

The company can be reached via phone at 44 33 3939 8091.

This page was last updated on 7/12/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.